Cbg Rich Genetics

CBG-rich genetics refer to cannabis cultivars selectively bred to express elevated cannabigerol (CBG) levels, often at the expense of THC or CBD dominance. CBG is a minor cannabinoid that serves as a precursor compound in the cannabinoid biosynthetic pathway; plants expressing CBG-rich phenotypes typically show altered enzymatic activity that diverts cannabinoid production toward CBG before conversion to other cannabinoids. Breeders working in this category often cross strains with genetic markers for CBG synthase expression or select from populations showing naturally higher CBG accumulation. Lineage records frequently report CBG-rich cultivars emerging from Swiss, Canadian, and EU breeding programs focused on minor cannabinoid research. These genetics remain relatively uncommon in commercial seed markets compared to THC or CBD-dominant families.

CBG-rich lines are primarily valuable for extraction and breeding research rather than traditional cultivation. Breeders use CBG-dominant parents to explore cannabinoid pathway genetics and develop dual-cannabinoid profiles in future generations.